CXCL9, an Early Inflammatory Marker As Prognostic Indicator Following Allogeneic Stem Cell Transplantation: A Single Prospective cohort study | Synapse
March 3, 2026
CXCL9, an Early Inflammatory Marker As Prognostic Indicator Following Allogeneic Stem Cell Transplantation: A Single Prospective cohort study
Key Points
CXCL9 levels indicate patient outcomes following allogeneic stem cell transplantation.
The study shows a significant correlation between CXCL9 and patient prognosis.
Observational analysis using a prospective cohort highlighted CXCL9 as a key inflammatory marker.
Understanding inflammatory markers like CXCL9 could improve post-transplant care strategies.